Boston Scientific Corp Stock Z Score

BSX Stock

USD 98.90 1.74 1.79%

Altman Z Score is one of the simplest fundamental models to determine how likely your company is to fail. The module uses available fundamental data of a given equity to approximate the Altman Z score. Altman Z Score is determined by evaluating five fundamental price points available from the company's current public disclosure documents. Check out Boston Scientific Piotroski F Score and Boston Scientific Valuation analysis.

At this time, Boston Scientific's Additional Paid In Capital is fairly stable compared to the past year. Net Working Capital is likely to rise to about 805.6 M in 2025, whereas Capital Surpluse is likely to drop slightly above 19.3 B in 2025. At this time, Boston Scientific's Net Income is fairly stable compared to the past year. Income Tax Expense is likely to rise to about 457.8 M in 2025, whereas Interest Expense is likely to drop slightly above 198.1 M in 2025.

Boston Scientific Corp Company Z Score Analysis

Boston Scientific's Z-Score is a simple linear, multi-factor model that measures the financial health and economic stability of a company. The score is used to predict the probability of a firm going into bankruptcy within next 24 months or two fiscal years from the day stated on the accounting statements used to calculate it. The model uses five fundamental business ratios that are weighted according to algorithm of Professor Edward Altman who developed it in the late 1960s at New York University..

Z Score

Sum Of

5 Factors

More About Z Score | All Equity Analysis

First Factor

1.2 * (

Working Capital

/

Total Assets )

Second Factor

1.4 * (

Retained Earnings

/

Total Assets )

Thrid Factor

3.3 * (

EBITAD

/

Total Assets )

Fouth Factor

0.6 * (

Market Value of Equity

/

Total Liabilities )

Fifth Factor

0.99 * (

Revenue

/

Total Assets )

Boston Z Score Driver Correlations

Understanding the fundamental principles of building solid financial models for Boston Scientific is extremely important. It helps to project a fair market value of Boston Stock properly, considering its historical fundamentals such as Z Score. Since Boston Scientific's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Boston Scientific's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Boston Scientific's interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Total Liab	Total Current Assets	Short Term Debt	Intangible Assets	Short Term Investments	Common Stock	Long Term Debt	Good Will	Treasury Stock	Property Plant Equipment	Current Deferred Revenue	Net Tangible Assets	Long Term Debt Total	Capital Surpluse	Deferred Long Term Liab	Long Term Investments	Short Long Term Debt	Cash And Equivalents	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.98	0.95	0.61	0.92	0.95	0.76	0.97	0.4	0.56	0.79	0.63	0.85	0.88	-0.74	0.83	-0.42	0.82	0.71	0.83	-0.6	0.68	0.3	0.65	0.88	0.77	0.76
Total Stockholder Equity	0.98		0.9	0.74	0.92	0.91	0.66	0.95	0.35	0.42	0.77	0.51	0.8	0.88	-0.65	0.81	-0.36	0.88	0.75	0.86	-0.51	0.63	0.27	0.68	0.92	0.8	0.82
Net Debt	0.95	0.9		0.55	0.88	0.95	0.78	0.91	0.54	0.59	0.85	0.62	0.84	0.81	-0.75	0.78	-0.51	0.73	0.71	0.76	-0.67	0.75	0.43	0.52	0.85	0.69	0.69
Retained Earnings	0.61	0.74	0.55		0.68	0.49	0.16	0.57	0.24	-0.22	0.61	-0.14	0.46	0.57	-0.21	0.48	-0.19	0.78	0.78	0.72	-0.16	0.43	0.21	0.59	0.84	0.69	0.76
Accounts Payable	0.92	0.92	0.88	0.68		0.91	0.64	0.91	0.42	0.34	0.84	0.52	0.76	0.83	-0.75	0.81	-0.51	0.84	0.72	0.87	-0.68	0.62	0.31	0.64	0.89	0.75	0.79
Net Receivables	0.95	0.91	0.95	0.49	0.91		0.73	0.91	0.55	0.61	0.77	0.69	0.74	0.82	-0.73	0.79	-0.42	0.75	0.56	0.76	-0.69	0.59	0.45	0.45	0.78	0.58	0.73
Total Liab	0.76	0.66	0.78	0.16	0.64	0.73		0.77	0.24	0.84	0.62	0.86	0.91	0.84	-0.79	0.86	-0.56	0.45	0.61	0.66	-0.61	0.65	0.12	0.51	0.65	0.59	0.38
Total Current Assets	0.97	0.95	0.91	0.57	0.91	0.91	0.77		0.35	0.51	0.81	0.64	0.86	0.84	-0.83	0.81	-0.46	0.83	0.72	0.85	-0.66	0.76	0.24	0.76	0.87	0.83	0.75
Short Term Debt	0.4	0.35	0.54	0.24	0.42	0.55	0.24	0.35		0.24	0.66	0.18	0.1	0.27	-0.25	0.24	-0.2	0.21	0.09	0.29	-0.38	0.34	0.98	-0.07	0.31	0.03	0.39
Intangible Assets	0.56	0.42	0.59	-0.22	0.34	0.61	0.84	0.51	0.24		0.3	0.88	0.62	0.58	-0.52	0.58	-0.3	0.11	0.15	0.25	-0.4	0.32	0.17	0.1	0.26	0.18	0.09
Short Term Investments	0.79	0.77	0.85	0.61	0.84	0.77	0.62	0.81	0.66	0.3		0.38	0.69	0.69	-0.69	0.68	-0.63	0.68	0.68	0.74	-0.67	0.8	0.55	0.59	0.81	0.73	0.62
Common Stock	0.63	0.51	0.62	-0.14	0.52	0.69	0.86	0.64	0.18	0.88	0.38		0.68	0.67	-0.73	0.71	-0.47	0.32	0.27	0.48	-0.64	0.45	0.07	0.29	0.37	0.31	0.31
Long Term Debt	0.85	0.8	0.84	0.46	0.76	0.74	0.91	0.86	0.1	0.62	0.69	0.68		0.87	-0.8	0.87	-0.58	0.66	0.85	0.79	-0.59	0.75	-0.03	0.72	0.84	0.83	0.53
Good Will	0.88	0.88	0.81	0.57	0.83	0.82	0.84	0.84	0.27	0.58	0.69	0.67	0.87		-0.65	0.97	-0.4	0.73	0.76	0.88	-0.49	0.57	0.18	0.61	0.86	0.7	0.7
Treasury Stock	-0.74	-0.65	-0.75	-0.21	-0.75	-0.73	-0.79	-0.83	-0.25	-0.52	-0.69	-0.73	-0.8	-0.65		-0.72	0.58	-0.59	-0.58	-0.69	0.84	-0.72	-0.08	-0.62	-0.66	-0.7	-0.46
Property Plant Equipment	0.83	0.81	0.78	0.48	0.81	0.79	0.86	0.81	0.24	0.58	0.68	0.71	0.87	0.97	-0.72		-0.46	0.72	0.75	0.88	-0.57	0.56	0.14	0.57	0.83	0.68	0.66
Current Deferred Revenue	-0.42	-0.36	-0.51	-0.19	-0.51	-0.42	-0.56	-0.46	-0.2	-0.3	-0.63	-0.47	-0.58	-0.4	0.58	-0.46		-0.3	-0.5	-0.43	0.71	-0.64	-0.1	-0.42	-0.45	-0.5	-0.22
Net Tangible Assets	0.82	0.88	0.73	0.78	0.84	0.75	0.45	0.83	0.21	0.11	0.68	0.32	0.66	0.73	-0.59	0.72	-0.3		0.74	0.86	-0.48	0.62	0.14	0.65	0.87	0.8	0.85
Long Term Debt Total	0.71	0.75	0.71	0.78	0.72	0.56	0.61	0.72	0.09	0.15	0.68	0.27	0.85	0.76	-0.58	0.75	-0.5	0.74		0.86	-0.41	0.72	-0.01	0.76	0.92	0.86	0.67
Capital Surpluse	0.83	0.86	0.76	0.72	0.87	0.76	0.66	0.85	0.29	0.25	0.74	0.48	0.79	0.88	-0.69	0.88	-0.43	0.86	0.86		-0.56	0.67	0.19	0.76	0.93	0.79	0.89
Deferred Long Term Liab	-0.6	-0.51	-0.67	-0.16	-0.68	-0.69	-0.61	-0.66	-0.38	-0.4	-0.67	-0.64	-0.59	-0.49	0.84	-0.57	0.71	-0.48	-0.41	-0.56		-0.63	-0.26	-0.39	-0.51	-0.47	-0.41
Long Term Investments	0.68	0.63	0.75	0.43	0.62	0.59	0.65	0.76	0.34	0.32	0.8	0.45	0.75	0.57	-0.72	0.56	-0.64	0.62	0.72	0.67	-0.63		0.21	0.67	0.69	0.76	0.52
Short Long Term Debt	0.3	0.27	0.43	0.21	0.31	0.45	0.12	0.24	0.98	0.17	0.55	0.07	-0.03	0.18	-0.08	0.14	-0.1	0.14	-0.01	0.19	-0.26	0.21		-0.17	0.22	-0.08	0.34
Cash And Equivalents	0.65	0.68	0.52	0.59	0.64	0.45	0.51	0.76	-0.07	0.1	0.59	0.29	0.72	0.61	-0.62	0.57	-0.42	0.65	0.76	0.76	-0.39	0.67	-0.17		0.75	0.91	0.6
Net Invested Capital	0.88	0.92	0.85	0.84	0.89	0.78	0.65	0.87	0.31	0.26	0.81	0.37	0.84	0.86	-0.66	0.83	-0.45	0.87	0.92	0.93	-0.51	0.69	0.22	0.75		0.87	0.82
Net Working Capital	0.77	0.8	0.69	0.69	0.75	0.58	0.59	0.83	0.03	0.18	0.73	0.31	0.83	0.7	-0.7	0.68	-0.5	0.8	0.86	0.79	-0.47	0.76	-0.08	0.91	0.87		0.59
Capital Stock	0.76	0.82	0.69	0.76	0.79	0.73	0.38	0.75	0.39	0.09	0.62	0.31	0.53	0.7	-0.46	0.66	-0.22	0.85	0.67	0.89	-0.41	0.52	0.34	0.6	0.82	0.59

Click cells to compare fundamentals

To calculate a Z-Score, one would need to know a company's current working capital, its total assets and liabilities, and the amount of its latest earnings as well as earnings before interest and tax. Z-Scores can be used to compare the odds of bankruptcy of companies in a similar line of business or firms operating in the same industry. Companies with Z-Scores above 3.1 are generally considered to be stable and healthy with a low probability of bankruptcy. Scores that fall between 1.8 and 3.1 lie in a so-called 'grey area,' with scores of less than 1 indicating the highest probability of distress. Z Score is a used widely measure by financial auditors, accountants, money managers, loan processors, wealth advisers, and day traders. In the last 25 years, many financial models that utilize z-scores proved it to be successful as a predictor of corporate bankruptcy.

Competition

Predict Boston Scientific

In accordance with the company's disclosures, Boston Scientific Corp has a Z Score of 0.0. This is 100.0% lower than that of the Health Care Equipment & Supplies sector and 100.0% lower than that of the Health Care industry. The z score for all United States stocks is 100.0% higher than that of the company.

Boston Scientific ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Boston Scientific's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Boston Scientific's managers, analysts, and investors.

Environmental

Governance

Social

Boston Scientific Institutional Holders

Institutional Holdings refers to the ownership stake in Boston Scientific that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Boston Scientific's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Boston Scientific's value.

		Shares
Bollard Group Llc	2024-12-31	20.7 M
Morgan Stanley - Brokerage Accounts	2024-12-31	20.5 M
Norges Bank	2024-12-31	19.7 M
Massachusetts Financial Services Company	2024-12-31	19.7 M
Franklin Resources Inc	2024-12-31	16.5 M
Amvescap Plc.	2024-12-31	15.8 M
Hhg Plc	2024-12-31	15 M
Northern Trust Corp	2024-12-31	14.6 M
Goldman Sachs Group Inc	2024-12-31	12.9 M
Blackrock Inc	2024-12-31	139 M
Vanguard Group Inc	2024-12-31	132.9 M

Boston Fundamentals

	Return On Equity	0.0889
	Return On Asset	0.0504
	Profit Margin	0.11 %
	Operating Margin	0.17 %
	Current Valuation	154.12 B
	Shares Outstanding	1.48 B
	Shares Owned By Insiders	0.19 %
	Shares Owned By Institutions	93.26 %
	Number Of Shares Shorted	12.87 M
	Price To Earning	107.05 X
	Price To Book	6.59 X
	Price To Sales	8.56 X
	Revenue	16.75 B
	Gross Profit	11.46 B
	EBITDA	2.6 B
	Net Income	1.85 B
	Cash And Equivalents	928 M
	Cash Per Share	0.24 X
	Total Debt	10.75 B
	Debt To Equity	0.51 %
	Current Ratio	1.45 X
	Book Value Per Share	14.76 X
	Cash Flow From Operations	3.44 B
	Short Ratio	1.82 X
	Earnings Per Share	1.25 X
	Price To Earnings To Growth	1.91 X
	Target Price	115.62
	Number Of Employees	53 K
	Beta	0.77
	Market Capitalization	143.39 B
	Total Asset	39.4 B
	Retained Earnings	2.67 B
	Working Capital	521 M
	Current Asset	1.21 B
	Current Liabilities	923 M
	Net Asset	39.4 B

About Boston Scientific Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Boston Scientific Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Boston Scientific using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Boston Scientific Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

V	Visa Class A
CRM	Salesforce
CRM	Salesforce

Additional Tools for Boston Stock Analysis

When running Boston Scientific's price analysis, check to measure Boston Scientific's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Boston Scientific is operating at the current time. Most of Boston Scientific's value examination focuses on studying past and present price action to predict the probability of Boston Scientific's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Boston Scientific's price. Additionally, you may evaluate how the addition of Boston Scientific to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Boston Scientific Corp Stock Z Score

Boston Scientific Corp Company Z Score Analysis

Z Score

Sum Of

5 Factors

First Factor

1.2 * (

Working Capital

/

Total Assets )

Second Factor

1.4 * (

Retained Earnings

/

Total Assets )

Thrid Factor

3.3 * (

EBITAD

/

Total Assets )

Fouth Factor

0.6 * (

Market Value of Equity

/

Total Liabilities )

Fifth Factor

0.99 * (

Revenue

/

Total Assets )

Boston Z Score Driver Correlations

Boston Scientific ESG Sustainability

Boston Scientific Institutional Holders

Boston Fundamentals

About Boston Scientific Fundamental Analysis

Also Currently Popular

Additional Tools for Boston Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY